For information on this past event please contact Meetings Management

Provisional Conference Program

Wednesday 19th April 2006

07.30 Onwards
Registration

08.50-09.00
Welcome to Vienna & Opening Remarks
Alexander von Gabain (Intercell AG, Vienna, Austria)

09.00-09.15
TBV 2006 Rapporteur’s Introduction
Rapporteur to be confirmed

SESSION 1:
OPENING PLENARY SESSION
Moderator: Michael Iademarco (CDC, USA)

09.15-09.45
‘Molecular medicine and the paradigm shift in the development of vaccines against microbial diseases’
Alex von Gabain (Intercell AG, Vienna, Austria)

09.45-10.15
‘A bolder notion of TB control’
Peter Small (Gates Foundation, Seattle, Washington, USA)

10.15-10.45
‘Global facilitation of TB vaccine development’
Uli Früth (WHO, Geneva, Switzerland)

10.45-11.15
Coffee Break & Posters Set-Up

SESSION 2:
PLENARY SESSION
Moderator: Alex von Gabain (Intercell AG, Vienna, Austria)

11.15-11.45
‘AERAS TB vaccine development’
Jerald C. Sadoff (AERAS, Bethesda, Maryland, USA)

11.45-12.15
‘TB-VAC – EU funded tuberculosis vaccine consortium update’
Paul-Henri Lambert (University of Geneva, Switzerland)

12.15-12.45
‘Overview of NIAID/NIH TB programs: The direction for TB vaccines’
Christine Sizemore (NIAID/NIH, Bethesda, Maryland, USA)

12.45 -14.00
Lunch & Posters

14.00-14.30
‘Background status and future plans of the TB vaccine program at GSK Biologicals’
Pascal Mettens (GSK Biologicals, Rixensart, Belgium)

14.30-15.00
‘BIO Ventures for Global Health Business case for TB vaccines: A market perspective’
Wendy Taylor (BIO Ventures for Global Health, Washington DC, USA)

15.00-16.00
SESSION 3:
STOP TB SPECIAL SESSION
Moderators: Uli Früth (WHO, Switzerland) & Douglas Young (Imperial College, London, UK)

‘Update on STOP TB initiative’
Drugs · Diagnostics · Vaccines

16.00-16.30
Tea Break & Posters

16.30-17.45
SESSION 4:
PREDICTING THE FUTURE OF TB VACCINES
Moderators: Odile Leroy and Michele Greco

Short presentations from:

Stefan Kaufmann (MPII, Berlin, Germany)
Peter Andersen (SSI, Copenhagen, Denmark)
Ripley Ballou (GSK Biologicals, Rixensart, Belgium)
Jerry Sadoff (AERAS, Washinton DC, USA)
Adrian Hill (University of Oxford, UK)
Ford von Reyn (Dartmouth Medical School, New Hampshire, USA)

Followed by an Open Panel Discussion

Evening:
Civic Reception